Core Insights - Huawei DCS leads the Chinese Software-Defined Compute (SDC) market with a 30% market share, ranking first in the sector [1] - In the virtualization software market, Huawei DCS holds a 28% market share, also ranking first [1] Group 1: Market Leadership - Huawei DCS has maintained its top position for four consecutive years, attributed to its core advantages of "security and reliability, extreme performance, and continuous innovation" [4] - The DCS eSphere serves as a core component for virtualization, enhancing resource utilization efficiency and gaining widespread trust in the global market [4] Group 2: Client Base and Industry Applications - Huawei DCS has served over 14,000 clients across more than 170 countries and regions, covering key industries such as government, finance, and healthcare [4] - In the government sector, Fujian Province has partnered with Huawei to implement a full-stack data center solution, ensuring stable operation of government applications [4] - The City of Ekurhuleni in South Africa has adopted Huawei's DCS solution to build a smart city, significantly reducing the time for new business deployment from days to hours [4] Group 3: Financial Sector Impact - Over 500 financial institutions have chosen Huawei DCS solutions for their digital transformation, including numerous domestic and international banks and insurance companies [5] - Anxin Securities has built a secure and stable financial data center based on Huawei DCS, achieving a 30% reduction in operational resource investment [5] Group 4: Healthcare Innovations - Shandong University Qilu Hospital has implemented Huawei DCS solutions to support various healthcare applications, enhancing patient access to medical services [5] - Shanghai Jiao Tong University School of Medicine's Ruijin Hospital has developed China's first clinical-grade pathology model using Huawei DCS AI solutions, significantly improving diagnostic efficiency [5]

Core Viewpoint - Shanghai Ruijin Hospital has launched the first open-source pathology model in collaboration with Huawei, covering seven common types of cancer and initiating a global multi-center plan for the RuiPath pathology model [1] Group 1: Model Development - The RuiPath pathology model is based on Huawei's DCS AI solution, which has been designed to address the needs of cancer diagnosis [1] - The model covers 90% of the annual incidence of common cancers in China, making it a significant advancement in the field of medical technology [1] Group 2: Cancer Types Covered - The open-source model includes data for lung cancer, colorectal cancer, thyroid cancer, gastric cancer, breast cancer, prostate cancer, and pancreatic cancer [1] Group 3: Data and Testing - Alongside the model, a supporting dataset for testing has been released, facilitating further research and development in pathology [1]